Best practice options for hair removal in patients with unwanted facial hair using combination therapy with laser: Guidelines drawn up by an expert working group

Dermatology

Volumn 221, Issue 1, 2010, Pages 34-42

  Lapidoth, M ^a   Dierickx, C ^b   Lanigan, S ^c   Paasch, U ^d   Campo Voegeli, A ^e   Dahan, S ^f   Marini, L ^g   Adatto, M ^h  

^a RABIN MEDICAL CENTER   (Israel)

^b Laser and Skin Center   (Belgium)

^c Sk:n   (United Kingdom)

^d UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^e HOSPITAL CLÍNIC   (Spain)

^f Clinique Saint Jean Languedoc   (France)

^g SDC the Skin Doctors' Center   (Italy)

^h Skinpulse Dermatology Laser and Beauty Centres   (Switzerland)

Author keywords

Eflornithine; Hair removal; Hirsutism; Laser; Unwanted facial hair

Indexed keywords

CYCLOSPORIN; DIAZOXIDE; EFLORNITHINE; GLUCOCORTICOID; MINOXIDIL; PLACEBO;

ACNE; BURN; CLINICAL TRIAL; DRUG SAFETY; ERYTHEMA; ESTHETIC SURGERY; HIRSUTISM; HUMAN; LASER SURGERY; LOW LEVEL LASER THERAPY; MEDICAL PRACTICE; PATHOGENESIS; PHYSICAL CHEMISTRY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RASH; REVIEW; SKIN MANIFESTATION; STINGING; TINGLING; TREATMENT OUTCOME;

COMBINED MODALITY THERAPY; EFLORNITHINE; FACE; FEMALE; HAIR REMOVAL; HIRSUTISM; HUMANS; LASER THERAPY; TREATMENT OUTCOME;

EID: 77955714568     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000315499     Document Type: Review

References (43)

1. Dorland's Illustrated Medical Dictionary, ed 31. Edinburgh, Elsevier Saunders, 2007.
2. Deplewski D, Rosenfield RL: Role of hormones in pilosebaceous unit development. Endocr Rev 2000; 21: 363-392.
3. Azziz R: The evaluation and management of hirsutism. Obstet Gynecol 2003; 101: 995-1007.
4. Jackson J, Caro JJ, Caro G, et al: The effect of eflornithine 13.9% cream on the bother and discomfort due to hirsutism. Int J Dermatol 2007; 46: 976-981.
5. Keegan A, Liao LM, Boyle M: 'Hirsutism': a psychological analysis. J Health Psychol 2003; 8: 327-345.
6. Barth JH, Catalan J, Cherry CA, et al: Psychological morbidity in women referred for treatment of hirsutism. J Psychosom Res 1993; 37: 615-619.
7. Sonino N, Fava GA, Mani E, et al: Quality of life of hirsute women. Postgrad Med J 1993; 69: 186-189.
8. Guidelines Working Party: Medical management of facial hirsutism: the outcomes of a guidelines working party. Primary Care Dermatology Society, 2005.
9. Blume-Peytavi U, Gieler U, Hoffmann R, et al: Unwanted facial hair: affects, effects and solutions. Dermatology 2007; 215: 139-146.
10. Yildiz BO, Bolour S, Woods K, et al: Visually scoring hirsutism. Hum Reprod Update 2009 Jun 30.
11. Azziz R, Woods KS, Reyna R, et al: The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004; 89: 2745-2749.
12. Dawber RP: Guidance for the management of hirsutism. Curr Med Res Opin 2005; 21: 1227-1234.
13. Watts J: Understanding the causes and management of hirsutism. Nurs Times 2006; 102: 26-28.
14. Moses R, Theile H, Colagiuri S: Postmenopausal hirsutism: the forgotten face. Aust N Z J Obstet Gynaecol 1994; 34: 500-501.
15. Mofid A, Seyyed Alinaghi SA, Zandieh S, et al: Hirsutism. Int J Clin Pract 2008; 62: 433-443.
16. Rittmaster RS: Hirsutism. Lancet 1997; 349: 191-195.
17. Blume-Peytavi U, Hahn S: Medical treatment of hirsutism. Dermatol Ther 2008; 21: 329-339.
18. Hunter MH, Carek PJ: Evaluation and treatment of women with hirsutism. Am Fam Physician 2003; 67: 2565-2572.
19. Koulouri O, Conway GS: Management of hirsutism. BMJ 2009; 338:b847.
20. Legro R: Management and treatment of hirsutism in the elderly woman. Ann Longterm Care 2002; 10: 41-47.
21. Anderson RR, Parrish JA: Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 1983; 220: 524-527.
22. Anderson RR, Parrish JA: The optics of human skin. J Invest Dermatol 1981; 77: 13-19.
23. Sanchez LA, Perez M, Azziz R: Laser hair reduction in the hirsute patient: a critical assessment. Hum Reprod Update 2002; 8: 169-181.
24. Alai NN, Saemi AM: Laser-assisted hair removal. eMedicine 2009 Jan 26.
25. Haedersdal M, Wulf HC: Evidence-based review of hair removal using lasers and light sources. J Eur Acad Dermatol Venereol 2006; 20: 9-20.
26. Haedersdal M, Gotzsche PC: Laser and photoepilation for unwanted hair growth. Cochrane Database Syst Rev 2006; 4:CD004684.
27. Davoudi SM, Behnia F, Gorouhi F, et al: Comparison of long-pulsed alexandrite and Nd:YAG lasers, individually and in combination, for leg hair reduction: an assessorblinded, randomized trial with 18 months of follow-up. Arch Dermatol 2008; 144: 1323-1327.
28. Clayton WJ, Lipton M, Elford J, et al: A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome. Br J Dermatol 2005; 152: 986-992.
29. Lolis MS, Marmur ES: Paradoxical effects of hair removal systems: a review. J Cosmet Dermatol 2006; 5: 274-276.
30. Hamzavi I, Tan E, Shapiro J, et al: A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women. J Am Acad Dermatol 2007; 57: 54-59.
31. Lim SP, Lanigan SW: A review of the adverse effects of laser hair removal. Lasers Med Sci 2006; 21: 121-125.
32. Halkiadakis I, Skouriotis S, Stefanaki C, et al: Iris atrophy and posterior synechiae as a complication of eyebrow laser epilation. J Am Acad Dermatol 2007; 57(2 suppl):S4-S5.
33. Herbold TM, Busse H, Uhlig CE: Bilateral cataract and corectopia after laser eyebrow [corrected] epilation. Ophthalmology 2005; 112: 1634-1635.
34. Wolf JE Jr, Shander D, Huber F, et al: Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair. Int J Dermatol 2007; 46: 94-98.
35. Vaniqa: Summary of product characteristics. 2008.
36. Hickman JG, Huber F, Palmisano M: Human dermal safety studies with eflornithine HCl 13.9% cream (Vaniqa), a novel treatment for excessive facial hair. Curr Med Res Opin 2001; 16: 235-244.
37. Malhotra B, Noveck R, Behr D, et al: Percutaneous absorption and pharmacokinetics of eflornithine HCl 13.9% cream in women with unwanted facial hair. J Clin Pharmacol 2001; 41: 972-978.
38. Claman P, Graves GR, Kredentser JV, et al: SOGC clinical practice guidelines. Hirsutism: evaluation and treatment. J Obstet Gynaecol Can 2002; 24: 62-69.
39. Ganger LK, Hamzavi IH: Excess salt and pepper hair treated with a combination of laser hair removal and topical eflornithine HCl. J Drugs Dermatol 2006; 5: 544-545.
40. Shapiro J, Lui H: Treatments for unwanted facial hair. Skin Therapy Lett 2005; 10(10):1-4.
41. Smith SR, Piacquadio DJ, Beger B, et al: Eflornithine cream combined with laser therapy in the management of unwanted facial hair growth in women: a randomized trial. Dermatol Surg 2006; 32: 1237-1243.
42. Elghblawi E: Idiopathic hirsutism: excessive bodily and facial hair in women. Br J Nurs 2008; 17: 192-197.
43. Hamzavi I, Owen MR: Eflornithine treatment of excess facial hair: a review. Dermatol Pract 2006; 13: 19-20.